Applications of IVIVC in Formulation Development - PQRI

More documents

Recommendations

Info

Level A IVIVC Validation – Acetate Buffer as Dissolution Medium Internal Predictability Formula Obs AUC Pred AUC %PE Obs C max Pred C max %PE Slow Release Fast Release 63.4 65.9 3.94 1.77 1.83 3.22 74.1 78.2 5.47 3.45 3.15 8.64 Average %PE 4.69 Average %PE 5.93 External Predictability Formula Obs AUC Pred AUC %PE Obs C max Pred C max %PE Medium Release 66.8 67.1 0.41 2.26 2.16 4.56 AUC units: ng-hr/mL, C max units: ng/mL
Dissolution of Target Formulation – Acetate Buffer as Dissolution Medium 100 Cumulative Percent Label Claim Dissolved 80 60 40 20 Medium Release Formulation Target Release Formulation Candidate Target Release Formulation 0 0 2 4 6 8 10 12 Time (Hours)
Page 1 and 2: Application of IVIVCs in Formulatio
Page 3 and 4: Applications of IVIVC Understandin
Page 5 and 6: Practical Application: In Vivo and
Page 7 and 8: Plasma Concentrations Following Ora
Page 9 and 10: IVIVC Model - Water as Dissolution
Page 11 and 12: Level A IVIVC Validation - Water as
Page 13: IVIVC Model - Acetate Buffer as Dis
Page 17 and 18: Level A IVIVC Validation - Acetate
Page 19 and 20: Case Study 2 BCS Class II Drug Hi
Page 21 and 22: Dissolution of Low Dose Reformulati
Page 23 and 24: Mean Dissolution and Absorption Pro
Page 25 and 26: Internal and External Predictabilit
Page 27 and 28: Dissolution Specifications For Low
Page 29 and 30: % Polymer Prediction Model to Achie
Page 31 and 32: Case Study 3 BCS Class I Drug Dev
Page 33 and 34: In Vitro / In Vivo Relationship for
Page 35 and 36: Demonstration of in vitro release i
Page 37 and 38: Internal Predictability Measures of
Page 39 and 40: MR Tablet Dissolution Profiles in 0
Page 41 and 42: 200 mg MR Tablet Dissolution Profil
Page 45 and 46: Approaches to a Level A IVIVC Trad
Page 47 and 48: MR Tablet Dissolution Profiles (Cum
Page 49 and 50: MR Tablets Absorption Profiles (Cum
Page 53 and 54: INTERNAL AND EXTERNAL PREDICTABILIT
Page 55 and 56: Case Study 5 BCS Class I Drug Dev
Page 57 and 58: Model of Fraction of Drug Absorbed
Page 59 and 60: Validation of the Model
Page 61 and 62: Conclusions-Benefits of IVIVC Prov
Page 63: Acknowledgements Pharmaceutical Sc

Applications of IVIVC in Formulation Development - PQRI

Create successful ePaper yourself

Delete template?

Save as template?